Positron Corp.

• Public
• US

Dow Jones Description

Positron Corporation (the Company) was incorporated in the State of Texas on December 20, 1983, and commenced commercial operations in 1986. The Company designs, manufactures, markets and services advanced medical imaging devices utilizing positron emission tomography ("PET) technology under the trade-name POSICAM systems. Unlike other currently available imaging technologies, PET technology permits the measurement of the biological processes of organs and tissues as well as producing anatomical and structural images. POSICAM systems, which incorporate patented and proprietary technology, enable physicians to diagnose and treat patients in the areas of cardiology, neurology and oncology. The Food and Drug Administration (FDA) approved the initial POSICAM system for marketing in 1985, and as of December 31, 2004, the Company has sold twenty eight (28) POSICAM systems, of which twelve (12) are in leading medical facilities in the United States and seven (7) are installed in international medical institutions. The Company has reacquired one system, which is being held in inventory for resale. The Company presently markets its POSICAM systems at list prices of up to $1.7 million depending upon the configuration and equipment options of the particular system.

Number of Employees 20

Contact Information

Peer Companies

• Canon Inc.
• Raytheon Co.
• Medtronic Inc.
• Danaher Corp.
• Thermo Fisher Scientific Inc.
• All Companies